Perceptions of dengue risk and acceptability of a dengue vaccine in residents of Puerto Rico

Perceptions of dengue risk and acceptability of a dengue vaccine in residents of Puerto Rico

ABSTRACTDengvaxia is the first dengue vaccine recommended in the United States (U.S.). It is recommended for children aged 9–16 y with laboratory-confirmed previous dengue infection and living in areas where dengue is endemic. We conducted focus groups with parents and in-depth interviews with key i...

Full description

Bibliographic Details
Main Authors: Coral Rosado-Santiago, Carmen L. Pérez-Guerra, Nicole M. Vélez-Agosto, Claudia Colón-Burgos, Karla M. Marrero-Santos, Susanna K. Partridge, Amy E. Lockwood, Cathy Young, Steve H. Waterman, Gabriela Paz-Bailey, Iris Cardona-Gerena, Angel Rivera, Laura E. Adams, Joshua M. Wong
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Dengue vaccine
Dengvaxia
vaccine acceptability
qualitative methods
Puerto Rico
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2024.2323264

Internet

https://www.tandfonline.com/doi/10.1080/21645515.2024.2323264

Similar Items